| Dr Annette Louise Athy, PHD | |
|
105 E 5th Ave, Augusta, KS 67010-1009 | |
| (316) 347-8700 | |
| Not Available |
| Full Name | Dr Annette Louise Athy |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 105 E 5th Ave, Augusta, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659354041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 352 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Annette Louise Athy, PHD 105 E 5th Ave, Augusta, KS 67010-1009 Ph: (316) 347-8700 | Dr Annette Louise Athy, PHD 105 E 5th Ave, Augusta, KS 67010-1009 Ph: (316) 347-8700 |
News Archive
Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species - mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.
St. Jude Medical, Inc., a global medical device company, today announced that physicians from the Cedars-Sinai Heart Institute will lead the company's transcatheter aortic valve implantation (TAVI) clinical trial. The study will evaluate the safety and efficacy of the St. Jude Medical transcatheter aortic valve for patients who experience severe aortic stenosis and who may be at an elevated risk for open-heart surgery.
In an article for Kaiser Health News and The Washington Post, Howard Gleckman writes about elder villages. "Nearly three years ago, Harry Rosenberg and his wife, Barbara Filner, met with nine of their neighbors about starting an aging-in-place "village" in the Burning Tree community of Bethesda, Maryland.
National Institutes of Health scientists and their colleagues have found evidence of the infectious agent of sporadic Creutzfeldt-Jakob disease (CJD) in the eyes of deceased CJD patients.
Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.
› Verified 5 days ago
Carla Morrow, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2821 Brookside Ct, Augusta, KS 67010 Phone: 316-425-0073 | |
Ms. Mandi J. Seachris, M.S., LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 520 E Augusta Ave, Augusta, KS 67010 Phone: 316-775-5491 Fax: 316-775-5442 | |
Suzanah Richelle Schoen, T-LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2821 South Brookside Drive, Augusta, KS 67010 Phone: 316-425-0073 | |
Shirley Fern Taylor, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2821 Brookside Ct, Augusta, KS 67010 Phone: 316-425-0073 | |
Mr. Peter E Lawlor, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1156 Henry St, Augusta, KS 67010 Phone: 316-775-2401 | |
Cheryl Parker, LBSW LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 520 E Augusta Ave, Augusta, KS 67010 Phone: 316-775-5491 |